As of 2025-10-14, the Relative Valuation of TherapeuticsMD Inc (TXMD) is (0.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.05 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -133.4%.
The range of the Relative Valuation is (0.27) - (0.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.9x - 6.8x | 6.5x |
| Forward P/E multiples | 6.7x - 14.7x | 11.2x |
| Fair Price | (0.27) - (0.27) | (0.35) |
| Upside | -125.4% - -125.6% | -133.4% |
| Date | P/E |
| 2025-10-13 | -26.46 |
| 2025-10-10 | -26.22 |
| 2025-10-09 | -26.72 |
| 2025-10-08 | -26.72 |
| 2025-10-07 | -27.22 |
| 2025-10-06 | -26.47 |
| 2025-10-03 | -27.03 |
| 2025-10-02 | -26.72 |
| 2025-10-01 | -26.72 |
| 2025-09-30 | -27.10 |
| 2025-09-29 | -27.22 |
| 2025-09-26 | -26.97 |
| 2025-09-25 | -26.72 |
| 2025-09-24 | -27.22 |
| 2025-09-23 | -26.97 |
| 2025-09-22 | -27.22 |
| 2025-09-19 | -27.48 |
| 2025-09-18 | -27.22 |
| 2025-09-17 | -26.72 |
| 2025-09-16 | -27.22 |
| 2025-09-15 | -27.22 |
| 2025-09-12 | -27.97 |
| 2025-09-11 | -27.98 |
| 2025-09-10 | -27.73 |
| 2025-09-09 | -27.22 |
| 2025-09-08 | -27.22 |
| 2025-09-05 | -27.22 |
| 2025-09-04 | -27.22 |
| 2025-09-03 | -27.85 |
| 2025-09-02 | -26.72 |
| 2025-08-29 | -27.98 |
| 2025-08-28 | -28.23 |
| 2025-08-27 | -28.23 |
| 2025-08-26 | -28.26 |
| 2025-08-25 | -27.98 |
| 2025-08-22 | -27.73 |
| 2025-08-21 | -27.22 |
| 2025-08-20 | -27.98 |
| 2025-08-19 | -29.24 |
| 2025-08-18 | -28.74 |
| 2025-08-15 | -29.49 |
| 2025-08-14 | -28.99 |
| 2025-08-13 | -29.24 |
| 2025-08-12 | -27.85 |
| 2025-08-11 | -27.22 |
| 2025-08-08 | -26.75 |
| 2025-08-07 | -27.73 |
| 2025-08-06 | -27.85 |
| 2025-08-05 | -27.73 |
| 2025-08-04 | -27.73 |